Browsing by Subject "Telomere-Binding Proteins"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Open Access Distinct functions of POT1 at telomeres.(2008) Kendellen, Megan FullerTelomeres are nucleoprotein complexes that constitute the ends of eukaryotic chromosomes. Telomeres differentiate the end of the chromosome from sites of DNA damage and control cellular replicative potential. The loss of function of telomeres results in several biological consequences. First, dysfunctional telomeres elicit DNA damage responses and repair activities, which frequently induce cytogenetic abnormalities and genomic instability that are characteristic of human cancer. Second, cellular immortalization resulting from inappropriate elongation of telomeres is a critical component of tumorigenesis. Alternatively, as telomere shortening limits replicative potential, abnormally short telomeres can result in premature cellular senescence that is associated with human pathology ranging from anemia to atherosclerosis. Telomeric DNA is composed of tandem repeats of G‐rich double‐stranded (ds)DNA that terminates in a G‐rich 3’ single‐stranded (ss)DNA overhang. Telomeres are thought to assume a lariat structure termed the t‐loop, which is decorated by an assortment of telomere‐associated proteins. The most unique and least well characterized of these proteins is POT1. POT1 binds telomeric ssDNA via a pair of Nterminal OB‐folds. Through its C‐terminal protein‐interaction domain, POT1 directly binds the telomeric dsDNA‐binding protein TRF2 and participates in heterodimeric complex with the protein TPP1. Inhibition of POT1 induces a robust DNA damage response at telomeres and deregulation of telomere length homeostasis, indicating that POT1 is important in maintaining telomere stability and in regulating telomere length. The goal of my thesis work was to determine which of the three major functions of POT1– telomeric ssDNA‐, TPP1‐, or TRF2‐binding – were required to properly localize POT1 to telomeres and to prevent the telomere instability and length deregulation that occur in the absence of POT1. Using separation‐of‐function mutants of POT1 deficient in at least one of these activities, I found that POT1 depends on its heterodimeric partner TPP1 in cis with telomeric ssDNA‐binding to preserve telomere stability, while POT1 depends on its protein interaction with TRF2 to localize to telomeres and its TRF2‐ and telomeric ssDNA‐binding activities in cis to regulate telomere length.Item Open Access Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk.(Int J Cancer, 2015-10-15) Brossard, Myriam; Fang, Shenying; Vaysse, Amaury; Wei, Qingyi; Chen, Wei V; Mohamdi, Hamida; Maubec, Eve; Lavielle, Nolwenn; Galan, Pilar; Lathrop, Mark; Avril, Marie-Françoise; Lee, Jeffrey E; Amos, Christopher I; Demenais, FlorenceGenome-wide association studies (GWASs) have characterized 13 loci associated with melanoma, which only account for a small part of melanoma risk. To identify new genes with too small an effect to be detected individually but which collectively influence melanoma risk and/or show interactive effects, we used a two-step analysis strategy including pathway analysis of genome-wide SNP data, in a first step, and epistasis analysis within significant pathways, in a second step. Pathway analysis, using the gene-set enrichment analysis (GSEA) approach and the gene ontology (GO) database, was applied to the outcomes of MELARISK (3,976 subjects) and MDACC (2,827 subjects) GWASs. Cross-gene SNP-SNP interaction analysis within melanoma-associated GOs was performed using the INTERSNP software. Five GO categories were significantly enriched in genes associated with melanoma (false discovery rate ≤ 5% in both studies): response to light stimulus, regulation of mitotic cell cycle, induction of programmed cell death, cytokine activity and oxidative phosphorylation. Epistasis analysis, within each of the five significant GOs, showed significant evidence for interaction for one SNP pair at TERF1 and AFAP1L2 loci (pmeta-int = 2.0 × 10(-7) , which met both the pathway and overall multiple-testing corrected thresholds that are equal to 9.8 × 10(-7) and 2.0 × 10(-7) , respectively) and suggestive evidence for another pair involving correlated SNPs at the same loci (pmeta-int = 3.6 × 10(-6) ). This interaction has important biological relevance given the key role of TERF1 in telomere biology and the reported physical interaction between TERF1 and AFAP1L2 proteins. This finding brings a novel piece of evidence for the emerging role of telomere dysfunction into melanoma development.Item Open Access Utility of telomerase-pot1 fusion protein in vascular tissue engineering.(Cell Transplant, 2010) Petersen, Thomas H; Hitchcock, Thomas; Muto, Akihito; Calle, Elizabeth A; Zhao, Liping; Gong, Zhaodi; Gui, Liqiong; Dardik, Alan; Bowles, Dawn E; Counter, Christopher M; Niklason, Laura EWhile advances in regenerative medicine and vascular tissue engineering have been substantial in recent years, important stumbling blocks remain. In particular, the limited life span of differentiated cells that are harvested from elderly human donors is an important limitation in many areas of regenerative medicine. Recently, a mutant of the human telomerase reverse transcriptase enzyme (TERT) was described, which is highly processive and elongates telomeres more rapidly than conventional telomerase. This mutant, called pot1-TERT, is a chimeric fusion between the DNA binding protein pot1 and TERT. Because pot1-TERT is highly processive, it is possible that transient delivery of this transgene to cells that are utilized in regenerative medicine applications may elongate telomeres and extend cellular life span while avoiding risks that are associated with retroviral or lentiviral vectors. In the present study, adenoviral delivery of pot1-TERT resulted in transient reconstitution of telomerase activity in human smooth muscle cells, as demonstrated by telomeric repeat amplification protocol (TRAP). In addition, human engineered vessels that were cultured using pot1-TERT-expressing cells had greater collagen content and somewhat better performance in vivo than control grafts. Hence, transient delivery of pot1-TERT to elderly human cells may be useful for increasing cellular life span and improving the functional characteristics of resultant tissue-engineered constructs.